Chronic Opioid Use after Surgery: Implications for Perioperative Management in the Face of the Opioid Epidemic

Anesthesia and Analgesia

Volumn 125, Issue 5, 2017, Pages 1733-1740

  Hah, Jennifer M ^a   Bateman, Brian T ^b   Ratliff, John ^c   Curtin, Catherine ^d   Sun, Eric ^c,e  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Department of Neurosurgery ^*  (United States)

^d Department of Orthopaedic Surgery   (United States)

^e STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LOCAL ANESTHETIC AGENT; OPIATE; ANALGESIC AGENT; NARCOTIC ANALGESIC AGENT;

ANALGESIA; ANESTHESIOLOGIST; APPENDECTOMY; CESAREAN SECTION; CHOLECYSTECTOMY; CHRONIC PAIN; DRUG MISUSE; EPIDEMIC; HEALTH CARE COST; HEMORRHOIDECTOMY; HOSPITAL PATIENT; HUMAN; LAPAROSCOPIC CHOLECYSTECTOMY; LUMPECTOMY; MORBIDITY; MORTALITY; OPIATE ADDICTION; OUTPATIENT; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PREDICTION; PRESCRIPTION; PREVALENCE; PRIORITY JOURNAL; RADICAL MASTECTOMY; REVIEW; RISK FACTOR; SIMPLE MASTECTOMY; SURGICAL PATIENT; THORACOTOMY; THYROIDECTOMY; TOTAL KNEE ARTHROPLASTY; UNITED STATES; DRUG ADMINISTRATION; INTEGRATED HEALTH CARE SYSTEM; MULTIMODALITY CANCER THERAPY; OPIOID-RELATED DISORDERS; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PATIENT CARE; PRESCRIPTION DRUG MISUSE; RISK ASSESSMENT; TREATMENT OUTCOME;

ANALGESICS, NON-NARCOTIC; ANALGESICS, OPIOID; COMBINED MODALITY THERAPY; DELIVERY OF HEALTH CARE, INTEGRATED; DRUG ADMINISTRATION SCHEDULE; EPIDEMICS; HUMANS; OPIOID-RELATED DISORDERS; PAIN MEASUREMENT; PAIN, POSTOPERATIVE; PATIENT CARE TEAM; PERIOPERATIVE CARE; PRESCRIPTION DRUG MISUSE; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 85032447299     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000002458     Document Type: Review

References (112)

1. Rudd RA Aleshire N Zibbell JE. Increases in drug and opioid overdose deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016; 64: 1378 1382.
2. Florence CS Zhou C Luo F. The economic burden of prescription opioid overdose, abuse, and dependence in the United States, 2013. Med Care. 2016; 54: 901 906.
3. de Beer Jde V Winemaker MJ Donnelly GA. Efficacy and safety of controlled-release oxycodone and standard therapies for postoperative pain after knee or hip replacement. Can J Surg. 2005; 48: 277 283.
4. Lindenhovius AL Helmerhorst GT Schnellen AC. Differences in prescription of narcotic pain medication after operative treatment of hip and ankle fractures in the United States and the Netherlands. J Trauma. 2009; 67: 160 164.
5. Fischer HB Simanski CJ. A procedure-specific systematic review and consensus recommendations for analgesia after total hip replacement. Anaesthesia. 2005; 60: 1189 1202.
6. Joshi GP Rawal N Kehlet H; PROSPECT Collaboration. Evidence-based management of postoperative pain in adults undergoing open inguinal hernia surgery. Br J Surg. 2012; 99: 168 185.
7. Roberts M Brodribb W Mitchell G. Reducing the pain: A systematic review of postdischarge analgesia following elective orthopedic surgery. Pain Med. 2012; 13: 711 727.
8. Wunsch H Wijeysundera DN Passarella MA. Opioids prescribed after low-risk surgical procedures in the United States, 2004-2012. JAMA. 2016; 315: 1654 1657.
9. Hooten WM St Sauver JL McGree ME Jacobson DJ Warner DO. Incidence and risk factors for progression from short-Term to episodic or long-Term opioid prescribing: A population-based study. Mayo Clin Proc. 2015; 90: 850 856.
10. Calcaterra SL Yamashita TE Min SJ Keniston A Frank JW Binswanger IA. Opioid prescribing at hospital discharge contributes to chronic opioid use. J Gen Intern Med. 2016; 31: 478 485.
11. Larochelle MR Liebschutz JM Zhang F Ross-Degnan D Wharam JF. Opioid prescribing after nonfatal overdose and association with repeated overdose: A cohort study. Ann Intern Med. 2016; 164: 1 9.
12. Maxwell JC. The prescription drug epidemic in the United States: A perfect storm. Drug Alcohol Rev. 2011; 30: 264 270.
13. Hays L Kirsh KL Passik SD. Seeking drug treatment for OxyContin abuse: A chart review of consecutive admissions to a substance abuse treatment facility in Kentucky. J Natl Compr Canc Netw. 2003; 1: 423 428.
14. Passik SD Hays L Eisner N Kirsh KL. Psychiatric and pain characteristics of prescription drug abusers entering drug rehabilitation. J Pain Palliat Care Pharmacother. 2006; 20: 5 13.
15. Potter JS Hennessy G Borrow JA Greenfield SF Weiss RD. Substance use histories in patients seeking treatment for controlled-release oxycodone dependence. Drug Alcohol Depend. 2004; 76: 213 215.
16. Ling W Mooney L Hillhouse M. Prescription opioid abuse, pain and addiction: clinical issues and implications. Drug Alcohol Rev. 2011; 30: 300 305.
17. Mudumbai SC Oliva EM Lewis ET. Time-To-cessation of postoperative opioids: A population-level analysis of the veterans affairs health care system. Pain Med. 2016; 17: 1732 1743.
18. Joseph EK Reichling DB Levine JD. Shared mechanisms for opioid tolerance and a transition to chronic pain. J Neurosci. 2010; 30: 4660 4666.
19. Vinik HR Kissin I. Rapid development of tolerance to analgesia during remifentanil infusion in humans. Anesth Analg. 1998; 86: 1307 1311.
20. Chia YY Liu K Wang JJ Kuo MC Ho ST. Intraoperative high dose fentanyl induces postoperative fentanyl tolerance. Can J Anaesth. 1999; 46: 872 877.
21. Guignard B Bossard AE Coste C. Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement. Anesthesiology. 2000; 93: 409 417.
22. Wright C Bigelow GE Stitzer ML Liebson IA. Acute physical dependence in humans: repeated naloxone-precipitated withdrawal after a single dose of methadone. Drug Alcohol Depend. 1991; 27: 139 148.
23. Athanasos P Smith CS White JM Somogyi AA Bochner F Ling W. Methadone maintenance patients are cross-Tolerant to the antinociceptive effects of very high plasma morphine concentrations. Pain. 2006; 120: 267 275.
24. Mojadadi S Jamali A Khansarinejad B Soleimanjahi H Bamdad T. Acute morphine administration reduces cell-mediated immunity and induces reactivation of latent herpes simplex virus type 1 in BALB/c mice. Cell Mol Immunol. 2009; 6: 111 116.
25. Wan Q Wang X Wang YJ Song L Wang SH Ho WZ. Morphine suppresses intracellular interferon-Alpha expression in neuronal cells. J Neuroimmunol. 2008; 199: 1 9.
26. Daniell HW. Hypogonadism in men consuming sustained-Action oral opioids. J Pain. 2002; 3: 377 384.
27. Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-Action opioids for control of nonmalignant pain. J Pain. 2008; 9: 28 36.
28. Daniell HW. DHEAS deficiency during consumption of sustained-Action prescribed opioids: evidence for opioid-induced inhibition of adrenal androgen production. J Pain. 2006; 7: 901 907.
29. Rajagopal A Vassilopoulou-Sellin R Palmer JL Kaur G Bruera E. Hypogonadism and sexual dysfunction in male cancer survivors receiving chronic opioid therapy. J Pain Symptom Manage. 2003; 26: 1055 1061.
30. Benyamin R Trescot AM Datta S. Opioid complications and side effects. Pain Physician. 2008; 11 2 suppl S105 S120.
31. Angst MS Koppert W Pahl I Clark DJ Schmelz M. Short-Term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain. 2003; 106: 49 57.
32. Chu LF Clark DJ Angst MS. Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: A preliminary prospective study. J Pain. 2006; 7: 43 48.
33. Chen L Malarick C Seefeld L Wang S Houghton M Mao J. Altered quantitative sensory testing outcome in subjects with opioid therapy. Pain. 2009; 143: 65 70.
34. White JM Irvine RJ. Mechanisms of fatal opioid overdose. Addiction. 1999; 94: 961 972.
35. Dahan A Aarts L Smith TW. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010; 112: 226 238.
36. Davies EC Green CF Taylor S Williamson PR Mottram DR Pirmohamed M. Adverse drug reactions in hospital in-patients: A prospective analysis of 3695 patient-episodes. PLoS One. 2009; 4: e4439.
37. Macintyre PE Loadsman JA Scott DA. Opioids, ventilation and acute pain management. Anaesth Intensive Care. 2011; 39: 545 558.
38. Overdyk F Dahan A Roozekrans M van der Schrier R Aarts L Niesters M. Opioid-induced respiratory depression in the acute care setting: A compendium of case reports. Pain Manag. 2014; 4: 317 325.
39. Zedler B Xie L Wang L. Risk factors for serious prescription opioid-related toxicity or overdose among Veterans Health Administration patients. Pain Med. 2014; 15: 1911 1929.
40. Overdyk FJ Dowling O Marino J. Association of opioids and sedatives with increased risk of in-hospital cardiopulmonary arrest from an administrative database. PLoS One. 2016; 11: e0150214.
41. Lee LA Caplan RA Stephens LS. Postoperative opioid-induced respiratory depression: A closed claims analysis. Anesthesiology. 2015; 122: 659 665.
42. Waljee JF Cron DC Steiger RM Zhong L Englesbe MJ Brummett CM. Effect of preoperative opioid exposure on healthcare utilization and expenditures following elective abdominal surgery. Ann Surg. 2017; 265: 715 721.
43. Ben-Ari A Chansky H Rozet I. Preoperative opioid use is associated with early revision after total knee arthroplasty: A study of male patients treated in the veterans affairs system. J Bone Joint Surg Am. 2017; 99: 1 9.
44. Mason MJ Golladay G Jiranek W. Depression moderates the relationship between pain and the nonmedical use of opioid medication among adult outpatients. J Addict Med. 2016; 10: 408 413.
45. Harris K Curtis J Larsen B. Opioid pain medication use after dermatologic surgery: A prospective observational study of 212 dermatologic surgery patients. JAMA Dermatol. 2013; 149: 317 321.
46. Bartels K Mayes LM Dingmann C Bullard KJ Hopfer CJ Binswanger IA. Opioid use and storage patterns by patients after hospital discharge following surgery. PLoS One. 2016; 11: e0147972.
47. Bates C Laciak R Southwick A Bishoff J. Overprescription of postoperative narcotics: A look at postoperative pain medication delivery, consumption and disposal in urological practice. J Urol. 2011; 185: 551 555.
48. Volkow ND McLellan AT. Opioid abuse in chronic pain-misconceptions and mitigation strategies. N Engl J Med. 2016; 374: 1253 1263.
49. Menendez ME Ring D Bateman BT. Preoperative opioid misuse is associated with increased morbidity and mortality after elective orthopaedic surgery. Clin Orthop Relat Res. 2015; 473: 2402 2412.
50. Hah JM Sharifzadeh Y Wang BM. Factors associated with opioid use in a cohort of patients presenting for surgery. Pain Res Treat. 2015; 2015: 829696.
51. Rodgers J Cunningham K Fitzgerald K Finnerty E. Opioid consumption following outpatient upper extremity surgery. J Hand Surg Am. 2012; 37: 645 650.
52. Alam A Gomes T Zheng H Mamdani MM Juurlink DN Bell CM. Long-Term analgesic use after low-risk surgery: A retrospective cohort study. Arch Intern Med. 2012; 172: 425 430.
53. Dowell D Haegerich TM Chou R. CDC guideline for prescribing opioids for chronic pain-United States, 2016. JAMA. 2016; 315: 1624 1645.
54. Bateman BT Franklin JM Bykov K. Persistent opioid use following cesarean delivery: patterns and predictors among opioid-naive women. Am J Obstet Gynecol. 2016; 215: 353.e351 353.e318.
55. Martin BC Fan MY Edlund MJ Devries A Braden JB Sullivan MD. Long-Term chronic opioid therapy discontinuation rates from the TROUP study. J Gen Intern Med. 2011; 26: 1450 1457.
56. Sun EC Darnall BD Baker LC Mackey S. Incidence of and risk factors for chronic opioid use among opioid-naive patients in the postoperative period. JAMA Intern Med. 2016; 176: 1286 1293.
57. Brummett CM Waljee JF Goesling J. New persistent opioid use after minor and major surgical procedures in US adults. JAMA Surg. 2017; 152: e170504.
58. Jiang X Orton M Feng R. Chronic opioid usage in surgical patients in a large academic center. Ann Surg. 2017; 265: 722 727.
59. Johnson SP Chung KC Zhong L. Risk of prolonged opioid use among opioid-naive patients following common hand surgery procedures. J Hand Surg Am. 2016; 41: 947 957.e3.
60. Waljee JF Zhong L Hou H. The use of opioid analgesics following common upper extremity surgical procedures: A national, population-based study. Plast Reconstr Surg. 2016; 137: 355e 364e.
61. Raebel MA Newcomer SR Bayliss EA. Chronic opioid use emerging after bariatric surgery. Pharmacoepidemiol Drug Saf. 2014; 23: 1247 1257.
62. Raebel MA Newcomer SR Reifler LM. Chronic use of opioid medications before and after bariatric surgery. JAMA. 2013; 310: 1369 1376.
63. Zarling BJ Yokhana SS Herzog DT Markel DC. Preoperative and postoperative opiate use by the arthroplasty patient. J Arthroplasty. 2016; 31: 2081 2084.
64. Anderson JT Haas AR Percy R. Chronic opioid therapy after lumbar fusion surgery for degenerative disc disease in a workers' compensation setting. Spine (Phila Pa 1976). 2015; 40: 1775 1784.
65. Kulshrestha S Barrantes F Samaniego M Luan FL. Chronic opioid analgesic usage post-kidney transplantation and clinical outcomes. Clin Transplant. 2014; 28: 1041 1046.
66. Carroll I Barelka P Wang CK. A pilot cohort study of the determinants of longitudinal opioid use after surgery. Anesth Analg. 2012; 115: 694 702.
67. Goesling J Moser SE Zaidi B. Trends and predictors of opioid use after total knee and total hip arthroplasty. Pain. 2016; 157: 1259 1265.
68. Inacio MC Hansen C Pratt NL Graves SE Roughead EE. Risk factors for persistent and new chronic opioid use in patients undergoing total hip arthroplasty: A retrospective cohort study. BMJ Open. 2016; 6: e010664.
69. Braden JB Sullivan MD Ray GT. Trends in long-Term opioid therapy for noncancer pain among persons with a history of depression. Gen Hosp Psychiatry. 2009; 31: 564 570.
70. Hah JM Mackey S Barelka PL. Self-loathing aspects of depression reduce postoperative opioid cessation rate. Pain Med. 2014; 15: 954 964.
71. Hall BJ Hood MM Nackers LM Azarbad L Ivan I Corsica J. Confirmatory factor analysis of the Beck Depression Inventory-II in bariatric surgery candidates. Psychol Assess. 2013; 25: 294 299.
72. Tully PJ Winefield HR Baker RA Turnbull DA de Jonge P. Confirmatory factor analysis of the Beck Depression Inventory-II and the association with cardiac morbidity and mortality after coronary revascularization. J Health Psychol. 2011; 16: 584 595.
73. Dahl JB Møiniche S. Pre-emptive analgesia. Br Med Bull. 2004; 71: 13 27.
74. Liu SS Buvanendran A Rathmell JP. A cross-sectional survey on prevalence and risk factors for persistent postsurgical pain 1 year after total hip and knee replacement. Reg Anesth Pain Med. 2012; 37: 415 422.
75. Vadivelu N Mitra S Schermer E Kodumudi V Kaye AD Urman RD. Preventive analgesia for postoperative pain control: A broader concept. Local Reg Anesth. 2014; 7: 17 22.
76. Kehlet H Jensen TS Woolf CJ. Persistent postsurgical pain: risk factors and prevention. Lancet. 2006; 367: 1618 1625.
77. Chan EY Fransen M Parker DA. Femoral nerve blocks for acute postoperative pain after knee replacement surgery. Cochrane Database Syst Rev. 2014; 5: CD009941.
78. Richman JM Liu SS Courpas G. Does continuous peripheral nerve block provide superior pain control to opioids? A meta-Analysis. Anesth Analg. 2006; 102: 248 257.
79. Memtsoudis SG Poeran J Cozowicz C Zubizarreta N Ozbek U Mazumdar M. The impact of peripheral nerve blocks on perioperative outcome in hip and knee arthroplasty-A population-based study. Pain. 2016; 157: 2341 2349.
80. Andreae MH Andreae DA. Regional anaesthesia to prevent chronic pain after surgery: A Cochrane systematic review and meta-Analysis. Br J Anaesth. 2013; 111: 711 720.
81. Ladha KS Patorno E Liu J Bateman BT. Impact of perioperative epidural placement on postdischarge opioid use in patients undergoing abdominal surgery. Anesthesiology. 2016; 124: 396 403.
82. Sun EC Bateman BT Memtsoudis SG Neuman MD Mariano ER Baker LC. Lack of association between the use of nerve blockade and the risk of postoperative chronic opioid use among patients undergoing total knee arthroplasty: evidence from the Market scan database. Anesth Analg. 2017; 125: 999 1007.
83. Mueller KG Memtsoudis SG Mariano ER Baker LC Mackey S Sun EC. Lack of association between the use of nerve blockade and the risk of persistent opioid use among patients undergoing shoulder arthroplasty: evidence from the Marketscan® database. Anesth Analg. 2017; 125: 1014 1020.
84. Dunn LK Durieux ME. Perioperative use of intravenous lidocaine. Anesthesiology. 2017; 126: 729 737.
85. Leliefeld PH Wessels CM Leenen LP Koenderman L Pillay J. The role of neutrophils in immune dysfunction during severe inflammation. Crit Care. 2016; 20: 73.
86. Hollmann MW Durieux ME. Local anesthetics and the inflammatory response: A new therapeutic indication? Anesthesiology. 2000; 93: 858 875.
87. Grigoras A Lee P Sattar F Shorten G. Perioperative intravenous lidocaine decreases the incidence of persistent pain after breast surgery. Clin J Pain. 2012; 28: 567 572.
88. Terkawi AS Sharma S Durieux ME Thammishetti S Brenin D Tiouririne M. Perioperative lidocaine infusion reduces the incidence of post-mastectomy chronic pain: A double-blind, placebo-controlled randomized trial. Pain Physician. 2015; 18: E139 E146.
89. Farag E Ghobrial M Sessler DI. Effect of perioperative intravenous lidocaine administration on pain, opioid consumption, and quality of life after complex spine surgery. Anesthesiology. 2013; 119: 932 940.
90. Loftus RW Yeager MP Clark JA. Intraoperative ketamine reduces perioperative opiate consumption in opiate-dependent patients with chronic back pain undergoing back surgery. Anesthesiology. 2010; 113: 639 646.
91. Suzuki M. Role of N-methyl-D-Aspartate receptor antagonists in postoperative pain management. Curr Opin Anaesthesiol. 2009; 22: 618 622.
92. Radvansky BM Shah K Parikh A Sifonios AN Le V Eloy JD. Role of ketamine in acute postoperative pain management: A narrative review. Biomed Res Int. 2015; 2015: 749837.
93. McNicol ED Tzortzopoulou A Cepeda MS. Single-dose intravenous paracetamol or propacetamol for prevention or treatment of postoperative pain: A systematic review and meta-Analysis. Br J Anaesth. 2011; 106: 764 775.
94. Macario A Royal MA. A literature review of randomized clinical trials of intravenous acetaminophen (paracetamol) for acute postoperative pain. Pain Pract. 2011; 11: 290 296.
95. Fassoulaki A Melemeni A Stamatakis E Petropoulos G Sarantopoulos C. A combination of gabapentin and local anaesthetics attenuates acute and late pain after abdominal hysterectomy. Eur J Anaesthesiol. 2007; 24: 521 528.
96. Sen H Sizlan A Yanarateş O. The effects of gabapentin on acute and chronic pain after inguinal herniorrhaphy. Eur J Anaesthesiol. 2009; 26: 772 776.
97. Yan PZ Butler PM Kurowski D Perloff MD. Beyond neuropathic pain: gabapentin use in cancer pain and perioperative pain. Clin J Pain. 2014; 30: 613 629.
98. Alayed N Alghanaim N Tan X Tulandi T. Preemptive use of gabapentin in abdominal hysterectomy: A systematic review and meta-Analysis. Obstet Gynecol. 2014; 123: 1221 1229.
99. Chou R Gordon DB de Leon-Casasola OA. Management of postoperative pain: A clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain. 2016; 17: 131 157.
100. Zhang S Paul J Nantha-Aree M. Reanalysis of morphine consumption from two randomized controlled trials of gabapentin using longitudinal statistical methods. J Pain Res. 2015; 8: 79 85.
101. Paul JE Nantha-Aree M Buckley N. Randomized controlled trial of gabapentin as an adjunct to perioperative analgesia in total hip arthroplasty patients. Can J Anaesth. 2015; 62: 476 484.
102. Clarke HA Katz J McCartney CJ. Perioperative gabapentin reduces 24 h opioid consumption and improves in-hospital rehabilitation but not post-discharge outcomes after total knee arthroplasty with peripheral nerve block. Br J Anaesth. 2014; 113: 855 864.
103. Grosen K Drewes AM Højsgaard A Pfeiffer-Jensen M Hjortdal VE Pilegaard HK. Perioperative gabapentin for the prevention of persistent pain after thoracotomy: A randomized controlled trial. Eur J Cardiothorac Surg. 2014; 46: 76 85.
104. Ladha KS Patorno E Huybrechts KF Liu J Rathmell JP Bateman BT. Variations in the use of perioperative multimodal analgesic therapy. Anesthesiology. 2016; 124: 837 845.
105. Arumugam S Lau CS Chamberlain RS. Use of preoperative gabapentin significantly reduces postoperative opioid consumption: A meta-Analysis. J Pain Res. 2016; 9: 631 640.
106. Fabritius ML Geisler A Petersen PL. Gabapentin for post-operative pain management-A systematic review with meta-Analyses and trial sequential analyses. Acta Anaesthesiol Scand. 2016; 60: 1188 1208.
107. Center for Substance Abuse Treatment. Enhancing Motivation for Change in Substance Abuse Treatment. Treatment Improvement Protocol (TIP) Series, No. 35. HHS Publication No. (SMA) 12-4212. 1999. Rockville, MD: Substance Abuse and Mental Health Services Administration.
108. Elia N Lysakowski C Tramèr MR. Does multimodal analgesia with acetaminophen, nonsteroidal antiinflammatory drugs, or selective cyclooxygenase-2 inhibitors and patient-controlled analgesia morphine offer advantages over morphine alone? Meta-Analyses of randomized trials. Anesthesiology. 2005; 103: 1296 1304.
109. Maund E McDaid C Rice S Wright K Jenkins B Woolacott N. Paracetamol and selective and non-selective non-steroidal anti-inflammatory drugs for the reduction in morphine-related side-effects after major surgery: A systematic review. Br J Anaesth. 2011; 106: 292 297.
110. McCarberg B. Washington state opioid prescribing guidelines. Pain Med. 2015; 16: 1455 1456.
111. Berna C Kulich RJ Rathmell JP. Tapering long-Term opioid therapy in chronic noncancer pain: evidence and recommendations for everyday practice. Mayo Clin Proc. 2015; 90: 828 842.
112. Oliva EM Christopher ML Wells D; Veterans Health Administration Opioid Overdose Education and Naloxone Distribution National Support and Development Workgroup. Opioid overdose education and naloxone distribution: development of the Veterans Health Administration's national program. J Am Pharm Assoc (2003). 2017; 57: S168 S179.e164.